Imagine the face of medicine transformed by technology, a world where scientific advances lead the way in operating rooms. Founded in synergy with the CNRS, Beams embarks on this thrilling adventure. This start-up specializes in the art of surgical procedures in oncology, making each surgical intervention not only more precise but especially safer. In 2005, it answered the call of Stéphane Palfi, a surgeon at Henri Mondor Hospital, by developing intraoperative probes. These innovative devices ensure real-time localization of residues, helping specialists navigate with ease in the microscopic world of cancer. This journey, guided by creativity and ingenuity, charts a new path in the field of health, redefining the standards of modern surgery.

Diving into the heart of cutting-edge medicine, Beams embodies the perfect fusion between human aspirations and the medical technologies of tomorrow. Born from a specific need expressed by a visionary surgeon at Henri Mondor Hospital in 2005, this project has become a true gateway to a new era for oncological surgery.

Beams has developed revolutionary intraoperative probes that, like magic wands, allow for the removal of tumor residues with formidable precision. Each surgical intervention resonates like a symphony: the actions, guided by technology, orchestrate a waltz between art and science, sweeping away any trace of danger within their reach.

Medically anchored at the forefront of medtech innovations, this spin-off of the prestigious CNRS symbolizes the commitment of researchers and developers in the relentless quest for safer, and above all, more humane solutions. The path of exploration is paved with challenges, but the courage and passionate determination of those at the helm of Beams promise a bright future.

the origin of beams

In 2005, the creation of Beams was born out of a specific need articulated by Stéphane Palfi, a renowned surgeon at Henri Mondor Hospital. Faced with the growing challenges in cancer surgery, he felt the necessity to push the boundaries of traditional medicine. The company, a spin-off of the CNRS, ventured into the field of medtech, specifically targeting surgical innovations in oncology. From its inception, Beams set itself the mission to improve the surgical gesture to provide unparalleled precision care.

innovations in surgical technology

The flagship project of Beams is its revolutionary intraoperative probe, which allows surgeons to locate tumor remnants in real-time, thus providing increased precision during interventions. With this device, Beams addresses a major issue: ensuring that every cancer cell is removed to reduce the risk of recurrence. Thanks to this advancement, practitioners can now perform safer procedures and foresee more promising outcomes for patients. Learn more about their development by following this link.

In parallel, the company cultivates a dynamic of open innovation, reinforcing its growth potential within innovation ecosystems. This approach has allowed it to push the limits of technology and collaborate with various stakeholders in the medical and technological fields to continuously improve its offerings.

transformations and future challenges

Beyond its innovations, Beams plays a key role in transforming contemporary surgical practices. By actively participating in the surgical and interventional innovation village, the company advocates for the adoption of cutting-edge technologies to revolutionize operational methods. These initiatives underscore the importance of a mental transformation among surgeons to optimize the use of available tools. Learn more here.